How Can Firms Avoid Falling Into GSK-Teva ‘Skinny Label’ Trap?
Industry Must Tread Carefully, Suggests Troy Groetken Of McAndrews, Held & Malloy
In the wake of a controversial US decision on carving out patented indications from generics labels, Troy Groetken of law firm McAndrews, Held & Malloy tells Generics Bulletin about the key issues that firms with ‘skinny label’ generics should be aware of given the potential for induced-infringement attacks.
